Clinical Trial Update: Cell Bank of Epstein Barr Virus Specific Cytotoxic T Lymphocytes [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a cell bank of Epstein-Barr virus-specific cytotoxic T lymphocytes for Epstein-Barr virus-associated lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus Associated Lymphoma

Drugs mentioned

• Cell Bank of Epstein-Barr Virus Specific Cytotoxic T Lymphocytes (Epstein-Barr virus-specific cytotoxic T lymphocytes)

Snippet

Sponsor: Nantes University Hospital | Conditions: EBV Associated Lymphoma | Phase 1 | Status: UNKNOWN